COMPARATIVE ANALYSIS OF THE CLINICAL EFFICACY OF COMBINED NEUROPROTECTION IN PATIENTS WITH ISCHEMIC STROKE ON THE BACKGROUND OF COVID-19

This article discusses the comparative analysis of the clinical efficacy of combined neuroprotection in patients with ischemic stroke on the background of COVID-19. To study the effect of the developed measures for drug and non-drug therapy, which included exercises (exercise therapy), patients were observed for the first 3 months of treatment. The second subgroup MG-2 received standard therapy with observation at the same time. Exercise therapy was developed in collaboration with instructors and rehabilitation specialists.

Перевод пока недоступен